Aadi Bioscience Ownership 2024 | Who Owns Aadi Bioscience Now?
Institutional Ownership
8.91%
Insider Ownership
10.79%
Retail Ownership
80.30%
Institutional Holders
27.00
Aadi Bioscience Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | 10.56% | 0.06% | 2,849,402 | - | - | 4,160,127 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 6.85% | 2.27% | 1,849,402 | - | - | 2,700,127 | Jun 30, 2024 |
| ALERCE INVESTMENT MANAGEMENT, L.P. | 6.04% | 4.67% | 1,630,830 | - | - | 2,381,012 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.84% | - | 765,992 | -90,844 | -10.60% | 1,118,348 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 1.89% | 0.07% | 509,572 | - | - | 743,975 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.63% | 0.00% | 439,222 | -104,500 | -19.22% | 641,264 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 1.31% | 0.28% | 352,483 | 34,344 | 10.80% | 514,625 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 1.24% | 0.04% | 333,227 | 333,227 | 100.00% | 486,511 | Jun 30, 2024 |
| BLACKROCK INC. | 1.19% | - | 320,247 | -720,759 | -69.24% | 467,560 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.84% | 0.00% | 226,085 | 226,085 | 100.00% | 330,084 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.77% | - | 206,443 | -192,788 | -48.29% | 301,488 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.59% | - | 158,680 | -124 | -0.08% | 231,673,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.57% | - | 154,270 | 104,691 | 211.16% | 225,234 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.31% | 0.00% | 82,361 | 50,166 | 155.82% | 120,247 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 0.30% | 0.01% | 80,000 | -120,000 | -60.00% | 116,800 | Jun 30, 2024 |
| UBS GROUP AG | 0.26% | - | 70,365 | 49,654 | 239.75% | 102,733 | Jun 30, 2024 |
| STATE STREET CORP | 0.25% | - | 68,737 | -306,410 | -81.68% | 100,356,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.24% | - | 64,904 | -399,562 | -86.03% | 94,760 | Jun 30, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | 0.24% | 0.02% | 63,564 | 5,757 | 9.96% | 92,804 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.18% | 0.00% | 48,960 | 48,960 | 100.00% | 71,482 | Jun 30, 2024 |
Aadi Bioscience's largest institutional shareholder is AVORO CAPITAL ADVISORS LLC, holding 10.56% of the company's total share outstanding, currently valued at $4.16M. The top 10 institutional shareholders own together 34.38% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALERCE INVESTMENT MANAGEMENT, L.P. | 6.04% | 4.67% | 1,630,830 | - | - | 2,381,012 | Jun 30, 2024 |
| ABG INNOVATION CAPITAL PARTNERS III GP LTD | 0.10% | 4.53% | 26,666 | - | - | 38,932 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 6.85% | 2.27% | 1,849,402 | - | - | 2,700,127 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 1.31% | 0.28% | 352,483 | 34,344 | 10.80% | 514,625 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 1.89% | 0.07% | 509,572 | - | - | 743,975 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 10.56% | 0.06% | 2,849,402 | - | - | 4,160,127 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 1.24% | 0.04% | 333,227 | 333,227 | 100.00% | 486,511 | Jun 30, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | 0.24% | 0.02% | 63,564 | 5,757 | 9.96% | 92,804 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 0.30% | 0.01% | 80,000 | -120,000 | -60.00% | 116,800 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.09% | 0.01% | 25,176 | 25,176 | 100.00% | 36,757 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.18% | 0.00% | 48,960 | 48,960 | 100.00% | 71,482 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.13% | 0.00% | 36,197 | -400 | -1.09% | 52,848 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.10% | 0.00% | 27,489 | 27,489 | 100.00% | 40,000 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.10% | 0.00% | 27,580 | 27,580 | 100.00% | 40,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.63% | 0.00% | 439,222 | -104,500 | -19.22% | 641,264 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.12% | 0.00% | 33,100 | 33,100 | 100.00% | 48,326 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.07% | 0.00% | 19,019 | 19,019 | 100.00% | 27,768 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.31% | 0.00% | 82,361 | 50,166 | 155.82% | 120,247 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.15% | 0.00% | 41,700 | - | - | 60,882 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.05% | 0.00% | 13,668 | 10,169 | 290.63% | 19,955 | Jun 30, 2024 |
The largest Aadi Bioscience shareholder by % of total assets is ALERCE INVESTMENT MANAGEMENT, L.P.. The company owns 1.63M shares of Aadi Bioscience (AADI), representing 4.67% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SOLEUS CAPITAL MANAGEMENT, L.P. | 1.24% | 0.04% | 333,227 | 333,227 | 100.00% | 486,511 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.84% | 0.00% | 226,085 | 226,085 | 100.00% | 330,084 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.57% | - | 154,270 | 104,691 | 211.16% | 225,234 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.31% | 0.00% | 82,361 | 50,166 | 155.82% | 120,247 | Jun 30, 2024 |
| UBS GROUP AG | 0.26% | - | 70,365 | 49,654 | 239.75% | 102,733 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.18% | 0.00% | 48,960 | 48,960 | 100.00% | 71,482 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 1.31% | 0.28% | 352,483 | 34,344 | 10.80% | 514,625 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.12% | 0.00% | 33,100 | 33,100 | 100.00% | 48,326 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.10% | 0.00% | 28,172 | 28,172 | 100.00% | 41,000 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.10% | 0.00% | 27,580 | 27,580 | 100.00% | 40,000 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.10% | 0.00% | 27,489 | 27,489 | 100.00% | 40,000 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.09% | 0.01% | 25,176 | 25,176 | 100.00% | 36,757 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.08% | - | 20,630 | 20,630 | 100.00% | 30,120 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.07% | 0.00% | 19,019 | 19,019 | 100.00% | 27,768 | Jun 30, 2024 |
| SEI INVESTMENTS CO | 0.06% | - | 15,749 | 15,749 | 100.00% | 22,994,000 | Jun 30, 2024 |
| FMR LLC | 0.06% | - | 16,944 | 12,935 | 322.65% | 24,738 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.04% | - | 12,071 | 12,071 | 100.00% | 17,624 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.05% | 0.00% | 13,668 | 10,169 | 290.63% | 19,955 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.03% | - | 8,135 | 8,135 | 100.00% | 11,877 | Jun 30, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | 0.24% | 0.02% | 63,564 | 5,757 | 9.96% | 92,804 | Jun 30, 2024 |
As of Jun 30 2024, Aadi Bioscience's largest institutional buyer is SOLEUS CAPITAL MANAGEMENT, L.P.. The company purchased 333.23K stocks of AADI, valued at $486.51K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 1.19% | - | 320,247 | -720,759 | -69.24% | 467,560 | Jun 30, 2024 |
| DECHENG CAPITAL LLC | - | - | - | -526,329 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.24% | - | 64,904 | -399,562 | -86.03% | 94,760 | Jun 30, 2024 |
| STATE STREET CORP | 0.25% | - | 68,737 | -306,410 | -81.68% | 100,356,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.77% | - | 206,443 | -192,788 | -48.29% | 301,488 | Jun 30, 2024 |
| PARALLEL ADVISORS, LLC | - | - | 8 | -161,188 | -100.00% | 12 | Jun 30, 2024 |
| STRS OHIO | - | - | - | -155,500 | -100.00% | - | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 0.30% | 0.01% | 80,000 | -120,000 | -60.00% | 116,800 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.63% | 0.00% | 439,222 | -104,500 | -19.22% | 641,264 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.84% | - | 765,992 | -90,844 | -10.60% | 1,118,348 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -43,858 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -37,075 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -26,500 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.07% | - | 17,796 | -23,292 | -56.69% | 25,982 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -21,355 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -20,913 | -100.00% | - | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.04% | - | 9,487 | -15,899 | -62.63% | 13,850 | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -11,356 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -10,731 | -100.00% | - | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -10,692 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Aadi Bioscience's biggest institutional seller is BLACKROCK INC.. The company sold -0.72M shares of AADI, valued at $467.56K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SOLEUS CAPITAL MANAGEMENT, L.P. | 1.24% | 0.04% | 333,227 | 333,227 | 100.00% | 486,511 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.84% | 0.00% | 226,085 | 226,085 | 100.00% | 330,084 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.18% | 0.00% | 48,960 | 48,960 | 100.00% | 71,482 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.12% | 0.00% | 33,100 | 33,100 | 100.00% | 48,326 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.10% | 0.00% | 28,172 | 28,172 | 100.00% | 41,000 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.10% | 0.00% | 27,580 | 27,580 | 100.00% | 40,000 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.10% | 0.00% | 27,489 | 27,489 | 100.00% | 40,000 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.09% | 0.01% | 25,176 | 25,176 | 100.00% | 36,757 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.07% | 0.00% | 19,019 | 19,019 | 100.00% | 27,768 | Jun 30, 2024 |
| SEI INVESTMENTS CO | 0.06% | - | 15,749 | 15,749 | 100.00% | 22,994,000 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.04% | - | 12,071 | 12,071 | 100.00% | 17,624 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.03% | - | 8,135 | 8,135 | 100.00% | 11,877 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.02% | 0.00% | 4,888 | 4,888 | 100.00% | 7,136 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.02% | - | 4,874 | 4,874 | 100.00% | 7,116 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.00% | - | 830 | 830 | 100.00% | 1,212 | Jun 30, 2024 |
| FARTHER FINANCE ADVISORS, LLC | 0.00% | - | 54 | 54 | 100.00% | 77 | Jun 30, 2024 |
Aadi Bioscience's largest new institutional shareholder by number of shares is SOLEUS CAPITAL MANAGEMENT, L.P., purchased 333.23K shares, valued at $486.51K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DECHENG CAPITAL LLC | - | - | - | -526,329 | -100.00% | - | Jun 30, 2024 |
| STRS OHIO | - | - | - | -155,500 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -43,858 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -37,075 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -26,500 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -21,355 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -20,913 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -11,356 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -10,731 | -100.00% | - | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -10,692 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -7,993 | -100.00% | - | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -1,842 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -1,484 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -1,086 | -100.00% | - | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | - | - | - | -970 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -502 | -100.00% | - | Jun 30, 2024 |
| PRIVATE WEALTH MANAGEMENT GROUP, LLC | - | - | - | -285 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -3 | -100.00% | - | Jun 30, 2024 |
Aadi Bioscience's largest sold out institutional shareholder by shares sold is DECHENG CAPITAL LLC, sold -0.53M shares, valued at -, as of undefined.
Aadi Bioscience Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. | 0.04% | 133,630 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.03% | 13,200 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 28,957 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.00% | 11,471 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 2,599 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 6,782 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 747,446 | -247,520 | -24.88% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 382 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 17,326 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 45,369 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 184,952 | 12,138 | 7.02% | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 5,352 | -828 | -13.40% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,086 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 10,337 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 7,681 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 7,920 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,122 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 10,349 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 306 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 963 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 2,314 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 6,854 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 3,700 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 70,995 | 8,224 | 13.10% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 148 | - | - | Dec 31, 2023 |
| iSHARES TRUST | 0.00% | 578,066 | -35,640 | -5.81% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 39,394 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 3,938 | -10,836 | -73.35% | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 3,890 | -3,433 | -46.88% | Mar 28, 2024 |
| Dimensional ETF Trust | 0.00% | 10,486 | - | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 6,224 | -25 | -0.40% | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 73 | - | - | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 500 | - | - | Mar 28, 2024 |
| ProFunds | 0.00% | 126 | -10 | -7.35% | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 1,315 | -15 | -1.13% | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,301 | 415 | 22.00% | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 2,374 | 282 | 13.48% | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 10 | - | - | Dec 31, 2023 |
| SPDR SERIES TRUST | 0.00% | 319,050 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 20,225 | - | - | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 15,604 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 5,529 | - | - | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 752 | - | - | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 1,838 | -7 | -0.38% | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 4,944 | - | - | Jan 31, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 17,761 | 4,735 | 36.35% | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 75 | - | - | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 354 | - | - | Feb 29, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 12,659 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 2,968 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 7,085 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 6,636 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 2,963 | - | - | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 1,681 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 2,258 | - | - | Jan 31, 2024 |
| John Hancock Funds II | 0.00% | 4,411 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 448 | 54 | 13.71% | Mar 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 2,900 | - | - | Feb 29, 2024 |
Aadi Bioscience's largest mutual fund holder by % of total assets is "T. Rowe Price Health Sciences Fund, Inc.", owning 133.63K shares, compromising 0.04% of its total assets.
Aadi Bioscience Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 27 | -55.74% |
| 31 Mar, 24 | 61 | -4.69% |
| 31 Dec, 23 | 64 | -11.11% |
| 30 Sep, 23 | 72 | 5.88% |
| 30 Jun, 23 | 68 | -4.23% |
| 31 Mar, 23 | 71 | -7.79% |
| 31 Dec, 22 | 77 | 10.00% |
| 30 Sep, 22 | 70 | 1.45% |
| 30 Jun, 22 | 69 | 23.21% |
| 31 Mar, 22 | 56 | 27.27% |
| 31 Dec, 21 | 44 | 46.67% |
| 30 Sep, 21 | 30 | - |
As of 30 Jun 24, 27 institutions are holding Aadi Bioscience's shares, representing a decrease of -55.74% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 2,405,313 | -81.79% |
| 31 Mar, 24 | 13,209,855 | 3.40% |
| 31 Dec, 23 | 12,775,643 | -13.24% |
| 30 Sep, 23 | 14,725,787 | 2.98% |
| 30 Jun, 23 | 14,299,789 | -0.29% |
| 31 Mar, 23 | 14,340,911 | -6.28% |
| 31 Dec, 22 | 15,301,593 | 1.54% |
| 30 Sep, 22 | 15,069,583 | 13.85% |
| 30 Jun, 22 | 13,236,386 | 4.01% |
| 31 Mar, 22 | 12,726,519 | 4.45% |
| 31 Dec, 21 | 12,184,145 | 9.80% |
| 30 Sep, 21 | 11,096,644 | - |
Aadi Bioscience (AADI) has 2.41M shares outstanding as of 30 Jun 24, down -81.79% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 8.91% | 0.37% |
| 31 Mar, 24 | 48.99% | 2.18% |
| 31 Dec, 23 | 47.41% | 1.58% |
| 30 Sep, 23 | 54.79% | 1.93% |
| 30 Jun, 23 | 53.23% | 1.87% |
| 31 Mar, 23 | 53.39% | 1.16% |
| 31 Dec, 22 | 67.97% | 1.35% |
| 30 Sep, 22 | 70.85% | 1.78% |
| 30 Jun, 22 | 63.12% | 1.70% |
| 31 Mar, 22 | 60.85% | 1.79% |
| 31 Dec, 21 | 58.32% | 2.07% |
| 30 Sep, 21 | 53.12% | - |
As of 30 Jun 24, Aadi Bioscience is held by 8.91% institutional shareholders, representing a 0.37% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 14 | -46.15% |
| 31 Mar, 24 | 26 | -25.71% |
| 31 Dec, 23 | 35 | 2.94% |
| 30 Sep, 23 | 34 | -2.86% |
| 30 Jun, 23 | 35 | 29.63% |
| 31 Mar, 23 | 27 | -18.18% |
| 31 Dec, 22 | 33 | -8.33% |
| 30 Sep, 22 | 36 | -7.69% |
| 30 Jun, 22 | 39 | 25.81% |
| 31 Mar, 22 | 31 | 3.33% |
| 31 Dec, 21 | 30 | - |
| 30 Sep, 21 | 30 | - |
14 institutional shareholders have increased their position in AADI stock as of 30 Jun 24 compared to 26 in the previous quarter (a -46.15% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 11 | -35.29% |
| 31 Mar, 24 | 17 | 70.00% |
| 31 Dec, 23 | 10 | -33.33% |
| 30 Sep, 23 | 15 | 15.38% |
| 30 Jun, 23 | 13 | -31.58% |
| 31 Mar, 23 | 19 | -13.64% |
| 31 Dec, 22 | 22 | 10.00% |
| 30 Sep, 22 | 20 | 17.65% |
| 30 Jun, 22 | 17 | 70.00% |
| 31 Mar, 22 | 10 | 100.00% |
| 31 Dec, 21 | 5 | - |
| 30 Sep, 21 | - | - |
11 institutional shareholders have reduced their position in AADI stock as of 30 Jun 24 compared to 17 in the previous quarter (a -35.29% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 27 | -55.74% | 2,405,313 | -81.79% | 8.91% | 0.37% | 14 | -46.15% | 11 | -35.29% |
| 31 Mar, 24 | 61 | -4.69% | 13,209,855 | 3.40% | 48.99% | 2.18% | 26 | -25.71% | 17 | 70.00% |
| 31 Dec, 23 | 64 | -11.11% | 12,775,643 | -13.24% | 47.41% | 1.58% | 35 | 2.94% | 10 | -33.33% |
| 30 Sep, 23 | 72 | 5.88% | 14,725,787 | 2.98% | 54.79% | 1.93% | 34 | -2.86% | 15 | 15.38% |
| 30 Jun, 23 | 68 | -4.23% | 14,299,789 | -0.29% | 53.23% | 1.87% | 35 | 29.63% | 13 | -31.58% |
| 31 Mar, 23 | 71 | -7.79% | 14,340,911 | -6.28% | 53.39% | 1.16% | 27 | -18.18% | 19 | -13.64% |
| 31 Dec, 22 | 77 | 10.00% | 15,301,593 | 1.54% | 67.97% | 1.35% | 33 | -8.33% | 22 | 10.00% |
| 30 Sep, 22 | 70 | 1.45% | 15,069,583 | 13.85% | 70.85% | 1.78% | 36 | -7.69% | 20 | 17.65% |
| 30 Jun, 22 | 69 | 23.21% | 13,236,386 | 4.01% | 63.12% | 1.70% | 39 | 25.81% | 17 | 70.00% |
| 31 Mar, 22 | 56 | 27.27% | 12,726,519 | 4.45% | 60.85% | 1.79% | 31 | 3.33% | 10 | 100.00% |
| 31 Dec, 21 | 44 | 46.67% | 12,184,145 | 9.80% | 58.32% | 2.07% | 30 | - | 5 | - |
| 30 Sep, 21 | 30 | - | 11,096,644 | - | 53.12% | - | 30 | - | - | - |
Aadi Bioscience Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Aadi Bioscience's stock was made by Desai Neil on Aug 05 2024, selling 15,415 shares at $1.50 per share (valued at $23.05K).
Aadi Bioscience Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 5 | - |
| Q2 2024 | 7 | 10 | 70.00% |
| Q1 2024 | 9 | 4 | 225.00% |
| Q4 2023 | 2 | 8 | 25.00% |
| Q3 2023 | - | 8 | - |
| Q2 2023 | 7 | 12 | 58.33% |
| Q1 2023 | 6 | - | - |
| Q3 2022 | 5 | - | - |
| Q2 2022 | 17 | - | - |
| Q1 2022 | - | 1 | - |
| Q4 2021 | 1 | 1 | 100.00% |
| Q3 2021 | 12 | 4 | 300.00% |
| Q2 2021 | 6 | - | - |
| Q1 2021 | 9 | - | - |
| Q4 2020 | 1 | 2 | 50.00% |
| Q2 2020 | 5 | - | - |
| Q1 2020 | 3 | - | - |
| Q4 2019 | 1 | 4 | 25.00% |
| Q3 2019 | 2 | - | - |
| Q2 2019 | 13 | 16 | 81.25% |
0 total buy trades, and 5 total sell trades (buy/sell ratio of 0.00%) were made by Aadi Bioscience's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 5 | - |
| Q2 2024 | - | 5 | - |
| Q1 2024 | - | 4 | - |
| Q4 2023 | - | 8 | - |
| Q3 2023 | - | 8 | - |
| Q2 2023 | - | 12 | - |
| Q1 2023 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | 1 | - |
| Q4 2021 | - | - | - |
| Q3 2021 | 3 | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | 1 | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | 2 | - | - |
| Q2 2019 | - | 16 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 5 open market sell trades of Aadi Bioscience's stocks.
Aadi Bioscience Peer Ownership
| Ticker | Company |
|---|---|
| GRCL | Gracell Biotechnologies Inc. |
| ANAB | AnaptysBio, Inc. |
| ARVN | Arvinas, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| MLYS | Mineralys Therapeutics, Inc. |
| AVTE | Aerovate Therapeutics, Inc. |
| ERAS | Erasca, Inc. |
| ACRV | Acrivon Therapeutics, Inc. Common Stock |
| ANTX | AN2 Therapeutics, Inc. |
| CRNX | Crinetics Pharmaceuticals, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| RZLT | Rezolute, Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| ADAG | Adagene Inc. |
| KURA | Kura Oncology, Inc. |
| RARE | Ultragenyx Pharmaceutical Inc. |
AADI Ownership FAQ
Who Owns Aadi Bioscience?
Aadi Bioscience is owned by institutional shareholders (8.91%), insiders (10.79%), and public (80.30%). The largest institutional shareholder of Aadi Bioscience is AVORO CAPITAL ADVISORS LLC (10.56% of total shares) and the top mutual fund owner is T. Rowe Price Health Sciences Fund, Inc. (0.04% of total shares).
Who are the major institutional shareholders of Aadi Bioscience?
Aadi Bioscience's major institutional shareholders are AVORO CAPITAL ADVISORS LLC, ACUTA CAPITAL PARTNERS, LLC, ALERCE INVESTMENT MANAGEMENT, L.P., VANGUARD GROUP INC, and VIVO CAPITAL, LLC. The top five shareholders own together 28.19% of the company's share outstanding.
How many Aadi Bioscience shareholders are there?
As of Jun 2024, there are 27 institutional shareholders of Aadi Bioscience.
What percentage of Aadi Bioscience is owned by AVORO CAPITAL ADVISORS LLC?
AVORO CAPITAL ADVISORS LLC owns 2.85M shares of Aadi Bioscience, representing 10.56% of the company's total shares outstanding, valued at $4.16M (as of Jun 2024).
What percentage of Aadi Bioscience is owned by ACUTA CAPITAL PARTNERS, LLC?
As of Jun 2024, ACUTA CAPITAL PARTNERS, LLC holds 1.85M shares of Aadi Bioscience (AADI), compromising 6.85% of the company, valued at $2.7M.
What percentage of Aadi Bioscience is owned by ALERCE INVESTMENT MANAGEMENT, L.P?
ALERCE INVESTMENT MANAGEMENT, L.P is the third largest holder of Aadi Bioscience. The company owns 1.63M of the company's shares outstanding (worth $2.38M).